MedTrace Logo

Improving Communication of Medication Instructions to Parents

NCT01834924 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1196

Last updated 2022-10-20

No results posted yet for this study

Summary

Almost half of all US adults have trouble understanding and using health information, or low health literacy. Health literacy is considered to be an important patient safety issue, and has been linked to poor medication management. Low health literacy is a risk factor for parent errors in administering medications to their children; difficulty understanding provider medication instructions is likely to contribute to errors.

To address these issues, bilingual (English/Spanish), low literacy, picture-based medication instruction sheets were developed. This study will look at the effectiveness and feasibility of the medication instruction sheet-based intervention as it is used by providers in 2 pediatric emergency department settings, as part of a planned roll out of HELPix within the hospital system. The investigators hypothesize that there will be reduced medication dosing errors, improved medication adherence, reduced hospital revisit rates, and improved provider-parent communication. The investigators also hypothesize that provider technology experience, knowledge, and attitudes, will affect the extent to which providers use the tool.

Conditions

  • Medication Errors
  • Medication Adherence

Interventions

OTHER

HELPix

Low literacy, bilingual (English/Spanish) medication instruction sheets used as a framework for provider medication counseling, plus provider dose demonstration, parent teachback/showback, provider medication log review, provision of oral dosing syringe to parent

Sponsors & Collaborators

  • New York City Health and Hospitals Corporation

    collaborator OTHER

  • Robert Wood Johnson Foundation

    collaborator OTHER

  • NYU Langone Health

    lead OTHER

Principal Investigators

  • H. Shonna Yin, MD, MS · NYU School of Medicine / Bellevue Hospital Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2015-01-09
Completion
2015-01-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01834924 on ClinicalTrials.gov